Figure 1From: Outcome and Human Epithelial Growth Factor Receptor (HER) 1-4 status in invasive breast carcinomas with proliferation indices evaluated using bromodeoxyuridine (BrdU) labellingSurvival curves (Kaplan-Meier) for BLI. Cumulative survival differences between patients whose tumours had high BLI values (≥ 75th percentile ie 6.4%) and low BLI values (<75th percentile). p-values represent log-rank differences in cumulative survival between the two groups.Back to article page